Abu-Amero Khaled K, Bosley Thomas M, Bohlega Saeed, Hansen Erik
Department of Genetics, King Faisal Specialist Hospital and Research Centre (MBC-03), P.O. Box 3354, Riyadh 11211, Saudi Arabia.
Ophthalmic Genet. 2005 Mar;26(1):31-6. doi: 10.1080/13816810590918235.
To assess the functional significance of the mitochondrial nt-9957 mutation in a man with non-arteritic ischemic optic neuropathy (NAION). This nt-9957 mutation has been previously reported in association with mitochondrial encephalopathy, lactic acidosis, and stroke-like events (MELAS).
The patient was examined clinically and with magnetic resonance imaging and spectroscopy. The entire coding region of the mitochondrial genome was sequenced, and mitochondrial function was assessed by flow cytometry after staining with fluorescent dihydroethidium.
This 76-year-old man had optic nerve disease bilaterally and seizures, but no clinical or radiological evidence of MELAS. He had no mitochondrial DNA mutation other than the 9957. Functional testing revealed a severe defect in mitochondrial complex III activity.
This patient had a mitochondrial functional deficit consistent with his 9957 mutation. It seems quite likely that this mutation may be responsible for optic nerve and brain injuries.
评估一名非动脉炎性缺血性视神经病变(NAION)男性患者中线粒体nt - 9957突变的功能意义。此前已有报道称该nt - 9957突变与线粒体脑肌病伴乳酸血症和卒中样发作(MELAS)相关。
对该患者进行了临床检查以及磁共振成像和波谱分析。对线粒体基因组的整个编码区域进行了测序,并用荧光二氢乙锭染色后通过流式细胞术评估线粒体功能。
这名76岁男性双侧患有视神经疾病且有癫痫发作,但无MELAS的临床或影像学证据。除9957外,他没有其他线粒体DNA突变。功能测试显示线粒体复合物III活性存在严重缺陷。
该患者存在与9957突变一致的线粒体功能缺陷。这种突变很可能是视神经和脑损伤的原因。